Application of proteomics for the identification of biomarkers in amniotic fluid: are we ready to provide a reliable prediction?

Proteomics-based identification of biomarkers for fetal abnormalities and pregnancy complications in amniotic fluid (AF) has made significant progress in the past 5 years. This is attributed mainly to advances in mass spectrometry-based proteomic technologies that enable new strategies for discoveri...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsangaris, George Th., Anagnostopoulos, Athanasios K., Tounta, Georgia, Antsaklis, Aris, Mavrou, Ariadni, Kolialexi, Aggeliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405381/
https://www.ncbi.nlm.nih.gov/pubmed/23199144
http://dx.doi.org/10.1007/s13167-011-0083-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405381/
https://www.ncbi.nlm.nih.gov/pubmed/23199144
http://dx.doi.org/10.1007/s13167-011-0083-0

Ejemplares similares